Omega-3 polyunsaturated fatty acid in peripheral arterial disease: Effect on lipid pattern, disease severity, inflammation profile, and endothelial function

Clinical Nutrition

Volumn 27, Issue 2, 2008, Pages 241-247

  Schiano, Vittorio ^a   Laurenzano, Eugenio ^a   Brevetti, Gregorio ^a   De Maio, Julieta Isabel ^a   Lanero, Simona ^a   Scopacasa, Francesco ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Endothelial function; Inflammation; Peripheral arterial disease; Polyunsaturated fatty acids

Indexed keywords

C REACTIVE PROTEIN; MYELOPEROXIDASE; OMEGA 3 FATTY ACID; THROMBOMODULIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY BLOOD FLOW; ARTERY DISEASE; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFLAMMATION; LIPID BLOOD LEVEL; MALE; PROTEIN BLOOD LEVEL; RISK REDUCTION; SENSITIVITY ANALYSIS; VASCULAR ENDOTHELIUM; VASODILATATION;

AGED; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; C-REACTIVE PROTEIN; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PEROXIDASE; REGIONAL BLOOD FLOW; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; THROMBOMODULIN; TREATMENT OUTCOME;

EID: 41349089494     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2007.11.007     Document Type: Article

References (39)

1. Daviglus M.L., Stamler J., Orencia A.J., et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 336 (1997) 1046-1053
2. Kromhout D., Bosschieter E.B., and de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312 (1985) 1205-1209
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results from the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
4. Tholstrup T., Hellgren L.I., Petersen M., et al. A solid dietary fat containing fish oil redistributes lipoprotein subclasses without increasing oxidative stress in men. J Nutr 134 (2004) 1051-1057
5. Robinson J.G., and Stone N.J. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol 98 (2006) 39i-49i
6. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21 (2002) 495-505
7. Goodfellow J., Bellamy M.F., Ramsey M.W., Jones C.J., and Lewis M.J. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 35 (2000) 265-270
8. Johansen O., Seljeflot I., Hostmark A.T., and Arnesen H. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 19 (1999) 1681-1686
9. Thies F., Garry J.M.C., Yaqoob P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized, controlled trial. Lancet 361 (2003) 477-485
10. Kris-Etherton P.M., Harris W.S., Appel L.J., American Heart Association, and Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
11. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
12. Brevetti G., Martone V.D., Perna S., et al. Intermittent claudication and risk of cardiovascular events. Angiology 49 (1998) 843-848
13. Leng G.C., Horrobin D.F., Fowkes F.G., et al. Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study. Arterioscler Thromb 14 (1994) 471-478
14. Christie S.B., Conway N., and Pearson H.E. Observations on the performance of a standard exercise test by claudicants taking gamma-linolenic acid. J Atheroscler Res 8 (1968) 83-90
15. Sommerfield T., and Hiatt W.R. Omega-3 fatty acids for intermittent claudication. Cochrane Database Syst Rev (2004) CD003833
16. Wildman R.P., Muntner P., Chen J., Sutton-Tyrrell K., and He J. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol 96 (2005) 1579-1583
17. Brevetti G., Silvestro A., Di Giacomo S., et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 38 (2003) 374-379
18. Rossi E., Biasucci L.M., Citterio F., et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 105 (2002) 800-803
19. Vainas T., Stassen F.R., de Graaf R., et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 42 (2005) 243-251
20. Brevetti G., Silvestro A., Schiano V., and Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108 (2003) 2093-2098
21. Gokce N., Keaney Jr. J.F., Hunter L.M., et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41 (2003) 1769-1775
22. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
23. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
24. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
25. Silvestro A., Brevetti G., Schiano V., Scopacasa F., and Chiariello M. Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification. Thromb Haemost 93 (2005) 559-563
26. Seljeflot I., Arnesen H., Brude I.R., Nenseter M.S., Drevon C.A., and Hjermann I. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur J Clin Invest 28 (1998) 629-635
27. Chowienczyk P.J., Watts G.F., Wierzbicki A.S., Cockcroft J.R., Brett S.E., and Ritter J.M. Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J Am Coll Cardiol 29 (1997) 964-968
28. Goode G.K., Garcia S., and Heagerty A.M. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. Circulation 96 (1997) 2802-2807
29. Okuda Y., Kawashima K., Sawada T., et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 232 (1997) 487-491
30. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
31. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
32. Burns T., Maciejewski S.R., Hamilton W.R., Zheng M., Mooss A.N., and Hilleman D.E. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio. Pharmacotherapy 27 (2007) 633-638
33. Madsen T., Christensen J.H., Blom M., and Schmidt E.B. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 89 (2003) 517-522
34. Chan D.C., Watts G.F., Barrett P.H., Beilin L.J., and Mori T.A. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem 48 (2002) 877-883
35. Lau D., and Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111 (2006) 16-26
36. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 347 (2002) 5-12
37. Baldus S., Heeschen C., Meinertz T., et al. CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
38. Abe Y., El-Masri B., Kimball K.T., et al. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 18 (1998) 723-731
39. Leng G.C., Lee A.J., Fowkes F.G., et al. Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease. Clin Nutr 17 (1998) 265-271